Search Suggestions:

  • Make sure all words are spelled correctly.
  • Try different keywords.
  • Try more general keywords.

Explore a next step for moderate to severe endometriosis pain relief

The first FDA-approved oral treatment for moderate to severe endometriosis pain in over a decade1,2

See how ORILISSA works

Learn how ORILISSA dials down estradiol to 2 different levels.

See pharmacology

Available in two oral dosages:

150 mg QD   200 mg BID

Two different doses allow you to individually tailor treatment.

See dosing
Dyspareunia Non-menstrual pelvic pain Dysmenorrhea

Dysmenorrhea

(150 mg QD or200 mg BID)

Non-menstrual Pelvic Pain

(150 mg QD or200 mg BID)

Dyspareunia*

(200 mg BID only)

*Statistical significance for dyspareunia was not achieved with the 150 mg QD dose of ORILISSA.

Custom HTML


A YEAR OF PATIENT EXPERIENCE

Over 10,000 HCPs have already prescribed ORILISSA for more than 30,000 patients3,4†


†These data reflect the number of HCPs who have prescribed and the number of women prescribed since ORILISSA was FDA-approved. Data sourced as of September 2019 and October 2019, respectively.

See how ORILISSA works

Back to top